Lansoprazol Teva

Lansoprazole, the active ingredient in Lansoprazol Teva, is a proton pump inhibitor presented as a tablet for oral, buccal, and sublingual use. It reduces gastric acid production and is used to treat acid‑related disorders in adults and children. GNH USA supplies Lansoprazol Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole is a proton pump inhibitor that addresses conditions caused by excess gastric acid. - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the esophageal lining. - Erosive oesophagitis: facilitates mucosal repair and reduces further injury. - Peptic ulcer disease: supports ulcer healing and prevents recurrence. - Helicobacter pylori eradication regimens: used in combination therapy to improve bacterial clearance.

Lansoprazole may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools occurring intermittently. - Nausea: feeling of stomach upset. - Abdominal pain: cramping or discomfort. - Flatulence: increased gas production. - Constipation: infrequent bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhea with abdominal pain. - Low magnesium levels: muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use.

Before using Lansoprazol Teva, consider the following safety measures. - Assess renal function: adjust use if severe impairment is present. - Review hepatic status: monitor if liver disease exists. - Evaluate for osteoporosis risk: prolonged therapy may affect bone density. - Monitor for infection signs: prolonged acid suppression can increase gastrointestinal infection risk. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Lansoprazole can affect the plasma concentrations of several co‑administered drugs.

Major Interactions (Avoid): - Antifungal agents (e.g., ketoconazole, itraconazole): reduced absorption and efficacy. - HIV protease inhibitors (e.g., atazanavir): markedly decreased serum levels.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in anticoagulant effect. - Methotrexate (high dose): possible increased toxicity. - Digoxin: modest rise in serum concentration.